Parkwood LLC’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Parkwood LLC’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,052	Closed	-$839K	–	173
2023 Q2	$839K	Buy	18,052 +433	+2%	+$15K	0.15%	91
2023 Q1	$505K	Buy	+17,619	New	+$522K	0.07%	114
2022 Q2	–	Sell	-12,417	Closed	-$238K	–	178
2022 Q1	$238K	Buy	+12,417	New	+$222K	0.04%	124

Parkwood LLC's DICE Position: Q3 2023 in Review

Parkwood LLC sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 18,052 shares — an estimated $839K sold.

Parkwood LLC first reported a position in DICE in Q1 2022 and held it in 3 quarters. The position peaked at $839K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Parkwood LLC reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Parkwood LLC sold 18,052 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $839K.
Parkwood LLC first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Parkwood LLC's DICE Therapeutics, Inc. Common Stock position peaked at $839K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Parkwood LLC's 13F filing for Q3 2023, filed 14 Nov 2023.